Rapid Micro Biosystems (RPID) Non Operating Interest Expenses (2020 - 2026)

Rapid Micro Biosystems has disclosed Non Operating Interest Expenses across 6 years of filings, most recently posting $646000.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses rose 5283.33% year-over-year to $646000.0; the TTM figure through Jun 2026 stood at $2.4 million (up 4902.13% YoY), while the FY2025 annual figure was $1.1 million, up 2625.0% from the prior year.
• Non Operating Interest Expenses came in at $646000.0 for Q2 2026 at Rapid Micro Biosystems, up from $639000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $673000.0 in Q4 2025 to a low of $10000.0 in Q2 2022.
• Average Non Operating Interest Expenses over 4 years is $241900.0, with a median of $12000.0 recorded in 2024.
• Year-over-year, Non Operating Interest Expenses tumbled 98.92% in 2022 and soared 5508.33% in 2025.
• Over 4 years, Non Operating Interest Expenses stood at $10000.0 in 2022, then grew by 20.0% to $12000.0 in 2024, then soared by 5508.33% to $673000.0 in 2025, then declined by 4.01% to $646000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $646000.0 in Q2 2026, $639000.0 in Q1 2026, and $673000.0 in Q4 2025.